|
C20ORF30 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.338160E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.537600E-03 |
| Normal-vs-Stage2 |
3.017200E-01 |
| Normal-vs-Stage3 |
5.138800E-01 |
| Normal-vs-Stage4 |
9.465400E-01 |
| Stage1-vs-Stage2 |
4.414200E-01 |
| Stage1-vs-Stage3 |
2.745600E-01 |
| Stage1-vs-Stage4 |
2.644200E-01 |
| Stage2-vs-Stage3 |
8.603200E-01 |
| Stage2-vs-Stage4 |
6.219200E-01 |
| Stage3-vs-Stage4 |
7.527600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.785700E-02 |
| Normal-vs-AfricanAmerican |
4.022800E-03 |
| Normal-vs-Asian |
3.619700E-02 |
| Caucasian-vs-AfricanAmerican |
6.541800E-02 |
| Caucasian-vs-Asian |
4.639000E-01 |
| AfricanAmerican-vs-Asian |
7.884600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.696700E-03 |
| Normal-vs-Female |
3.592600E-01 |
| Male-vs-Female |
7.782300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.460590E-01 |
| Normal-vs-Extreme_Weight |
2.714100E-02 |
| Normal-vs-Obese |
1.586570E-01 |
| Normal-vs-Extreme_Obese |
4.535500E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.401000E-01 |
| Normal_Weight-vs-Obese |
9.061600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.884200E-01 |
| Extreme_Weight-vs-Obese |
5.219000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.879600E-01 |
| Obese-vs-Extreme_Obese |
4.641200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.976600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.859800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.778570E-03 |
| Normal-vs-Age(81-100Yrs) |
7.935300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.766400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.843600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.698800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.758400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.746790E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.814200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.581900E-02 |
| Normal-VS-Type2 PRCC |
1.979990E-03 |
| Normal-VS-KIRP CIMP |
6.117800E-01 |
| Normal-VS-Unclassified PRCC |
5.990400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.018400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.105400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.586400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.357400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.361580E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.610600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.168000E-02 |
| Normal-vs-N1 |
5.863400E-01 |
| Normal-vs-N2 |
3.075000E-01 |
| N0-vs-N1 |
3.017200E-01 |
| N0-vs-N2 |
8.843200E-01 |
| N1-vs-N2 |
7.194800E-01 |
|
|
